Alteration in immunoreactivity associated with tumor-bearing is well recognized ; however, the mechanisms of immunoregulation are still elusive, and little is known about their effects on immunotherapy with the use of lymphokine-activated killer(LAK) cells. A rat subcutane- ous tumor-host model using a gliosarcoma cell line(T9) syngeneic to F344 rats was established, whereby alteration in the proliferation or cytotoxic activities of spleen cells of tumor-bearing hosts were assessed, and subsequently its cellular as well as humoral mechanisms and also its effects on the induction and cytotoxicity of LAK cells were analyzed. The rats showed splenomegaly with the growth of the tumor with more than a 2-fold increase in spleen cell number for 2w...
An in vitro system for the study of the cell-mediated immune response to Jensen Sarcoma (JS) is desc...
Lymphokine-activated killer (LAK) cells can be generated by incubating peripheral blood lymphocytes ...
<p>Tumoral infiltration of cells positive for CD3<sup>+</sup>, CD8a<sup>+</sup>, CD161 (NK cell), or...
Alteration in immunoreactivity associated with tumor-bearing is well recognized ; however, the mecha...
Adoptive immunotherapy with lymphokine activated killer (LAK) cells and interleukin-2 (IL-2) has bee...
Adoptive immunotherapy with lymphokine activated killer (LAK) cells and interleukin-2 (IL-2) has bee...
Fischer rats gained immunity against syngeneic gliosarcoma cells (T9) after repeated immunization wi...
Tumor-specific cellular immunity to tumor antigens was demonstrated in vitro by mixed lymphocyt tumo...
Spleens from W/Fu rats bearing a syngeneic progressively growing (C58NT)D tumor contain cells which ...
Subcutaneous injection of 10? syngeneic gliosarcoma (T-9) cells is enough to kill Fisher rats within...
Fischer rats gained immunity against syngeneic gliosarcoma cells (T9) after repeated immunization wi...
Subcutaneous injection of 10? syngeneic gliosarcoma (T-9) cells is enough to kill Fisher rats within...
An in vitro technique was developed to generate activated rat T cells, with antitumor activity. Sple...
Lymphokine activated killer (LAK) cells are efficient mediators of tumour destruction in experimenta...
P815 X2 mastocytoma cells, when injected subcutaneously into syngeneic DBA/2 mice, induced T lymphoc...
An in vitro system for the study of the cell-mediated immune response to Jensen Sarcoma (JS) is desc...
Lymphokine-activated killer (LAK) cells can be generated by incubating peripheral blood lymphocytes ...
<p>Tumoral infiltration of cells positive for CD3<sup>+</sup>, CD8a<sup>+</sup>, CD161 (NK cell), or...
Alteration in immunoreactivity associated with tumor-bearing is well recognized ; however, the mecha...
Adoptive immunotherapy with lymphokine activated killer (LAK) cells and interleukin-2 (IL-2) has bee...
Adoptive immunotherapy with lymphokine activated killer (LAK) cells and interleukin-2 (IL-2) has bee...
Fischer rats gained immunity against syngeneic gliosarcoma cells (T9) after repeated immunization wi...
Tumor-specific cellular immunity to tumor antigens was demonstrated in vitro by mixed lymphocyt tumo...
Spleens from W/Fu rats bearing a syngeneic progressively growing (C58NT)D tumor contain cells which ...
Subcutaneous injection of 10? syngeneic gliosarcoma (T-9) cells is enough to kill Fisher rats within...
Fischer rats gained immunity against syngeneic gliosarcoma cells (T9) after repeated immunization wi...
Subcutaneous injection of 10? syngeneic gliosarcoma (T-9) cells is enough to kill Fisher rats within...
An in vitro technique was developed to generate activated rat T cells, with antitumor activity. Sple...
Lymphokine activated killer (LAK) cells are efficient mediators of tumour destruction in experimenta...
P815 X2 mastocytoma cells, when injected subcutaneously into syngeneic DBA/2 mice, induced T lymphoc...
An in vitro system for the study of the cell-mediated immune response to Jensen Sarcoma (JS) is desc...
Lymphokine-activated killer (LAK) cells can be generated by incubating peripheral blood lymphocytes ...
<p>Tumoral infiltration of cells positive for CD3<sup>+</sup>, CD8a<sup>+</sup>, CD161 (NK cell), or...